Phosphorylation of the S6 protein, mediated by S6K activity, an mTOR target, was significantly higher in CCRCC compared to other RCC subtypes and is associated with poorer outcome [30]. This evidence concerns the gene MTOR and nonpapillary renal cell carcinoma.